PHYSICIANS REALTY TRUST: 10-K filed 2017-02-24
What PHYSICIANS REALTY TRUST reported in its annual report filed 2017-02-24 (fiscal FY 2016): 26 published measures, 118 facts as tagged in accession 0001574540-17-000007.
This filing
- Form
- 10-K (annual report)
- Filed
- 2017-02-24
- Fiscal period
- fiscal FY 2016
- Accession
- 0001574540-17-000007 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHYSICIANS REALTY TRUST filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 2,888,092,000 | USD | |
| At 2015-12-31 | 1,638,886,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 1,079,297,000 | USD | |
| At 2015-12-31 | 535,465,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 1,738,451,000 | USD | |
| At 2015-12-31 | 1,021,132,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 15,491,000 | USD | |
| At 2015-12-31 | 3,143,000 | USD | |
| At 2014-12-31 | 15,923,000 | USD | |
| At 2013-12-31 | 56,478,000 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 124,779,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 61,352,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 13,295,000 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 1,148,745,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 727,584,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 464,960,000 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | -1,261,176,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | -801,716,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | -518,810,000 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | -197,261,000 | USD | |
| At 2015-12-31 | -109,024,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 135,581,976 | shares | 92 |
| 2016-07-01 to 2016-09-30 | 134,608,396 | shares | 92 |
| 2016-04-01 to 2016-06-30 | 131,481,329 | shares | 91 |
| 2016-01-01 to 2016-03-31 | 102,704,008 | shares | 91 |
| 2015-10-01 to 2015-12-31 | 83,761,536 | shares | 92 |
| 2015-07-01 to 2015-09-30 | 71,034,747 | shares | 92 |
| 2015-04-01 to 2015-06-30 | 70,376,959 | shares | 91 |
| 2015-01-01 to 2015-03-31 | 65,649,478 | shares | 90 |
| 2014-01-01 to 2014-12-31 | 33,063,093 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 139,602,349 | shares | 92 |
| 2016-01-01 to 2016-12-31 | 130,466,893 | shares | 366 |
| 2016-07-01 to 2016-09-30 | 138,880,787 | shares | 92 |
| 2016-04-01 to 2016-06-30 | 135,944,722 | shares | 91 |
| 2016-01-01 to 2016-03-31 | 107,148,380 | shares | 91 |
| 2015-10-01 to 2015-12-31 | 87,911,097 | shares | 92 |
| 2015-01-01 to 2015-12-31 | 76,792,073 | shares | 365 |
| 2015-07-01 to 2015-09-30 | 75,104,821 | shares | 92 |
| 2015-04-01 to 2015-06-30 | 74,267,284 | shares | 91 |
| 2015-01-01 to 2015-03-31 | 65,649,478 | shares | 90 |
| 2014-01-01 to 2014-12-31 | 33,063,093 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 0.06 | USD/shares | 92 |
| 2016-01-01 to 2016-12-31 | 0.22 | USD/shares | 366 |
| 2016-07-01 to 2016-09-30 | 0.07 | USD/shares | 92 |
| 2016-04-01 to 2016-06-30 | 0.05 | USD/shares | 91 |
| 2016-01-01 to 2016-03-31 | 0.04 | USD/shares | 91 |
| 2015-10-01 to 2015-12-31 | 0.06 | USD/shares | 92 |
| 2015-01-01 to 2015-12-31 | 0.15 | USD/shares | 365 |
| 2015-07-01 to 2015-09-30 | 0.05 | USD/shares | 92 |
| 2015-04-01 to 2015-06-30 | 0.04 | USD/shares | 91 |
| 2015-01-01 to 2015-03-31 | -0.01 | USD/shares | 90 |
| 2014-01-01 to 2014-12-31 | -0.12 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 0.06 | USD/shares | 92 |
| 2016-01-01 to 2016-12-31 | 0.22 | USD/shares | 366 |
| 2016-07-01 to 2016-09-30 | 0.07 | USD/shares | 92 |
| 2016-04-01 to 2016-06-30 | 0.05 | USD/shares | 91 |
| 2016-01-01 to 2016-03-31 | 0.04 | USD/shares | 91 |
| 2015-10-01 to 2015-12-31 | 0.06 | USD/shares | 92 |
| 2015-01-01 to 2015-12-31 | 0.15 | USD/shares | 365 |
| 2015-07-01 to 2015-09-30 | 0.05 | USD/shares | 92 |
| 2015-04-01 to 2015-06-30 | 0.04 | USD/shares | 91 |
| 2015-01-01 to 2015-03-31 | -0.01 | USD/shares | 90 |
| 2014-01-01 to 2014-12-31 | -0.12 | USD/shares | 365 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 4,894,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 3,798,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 2,422,000 | USD | 365 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 23,864,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 10,636,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 6,907,000 | USD | 365 |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 238,285,000 | USD | |
| At 2015-12-31 | 175,160,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 0 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 606,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 321,000 | USD | 365 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 209,627,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 116,934,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 57,879,000 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 135,966,013 | shares | |
| At 2015-12-31 | 86,864,063 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 13,708,000 | USD | |
| At 2015-12-31 | 0 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 1,782,318,000 | USD | |
| At 2015-12-31 | 1,076,461,000 | USD | |
| At 2014-12-31 | 569,209,000 | USD | |
| At 2013-12-31 | 240,837,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-12-31 | 991,155,000 | USD | |
| At 2015-12-31 | 483,615,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 8,620,000 | USD | 92 |
| 2016-01-01 to 2016-12-31 | 31,522,000 | USD | 366 |
| 2016-07-01 to 2016-09-30 | 10,294,000 | USD | 92 |
| 2016-04-01 to 2016-06-30 | 7,184,000 | USD | 91 |
| 2016-01-01 to 2016-03-31 | 5,424,000 | USD | 91 |
| 2015-10-01 to 2015-12-31 | 5,909,000 | USD | 92 |
| 2015-01-01 to 2015-12-31 | 12,741,000 | USD | 365 |
| 2015-07-01 to 2015-09-30 | 3,983,000 | USD | 92 |
| 2015-04-01 to 2015-06-30 | 3,297,000 | USD | 91 |
| 2015-01-01 to 2015-03-31 | -448,000 | USD | 90 |
| 2014-01-01 to 2014-12-31 | -4,418,000 | USD | 365 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 43,352,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 11,788,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | -4,037,000 | USD | 365 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-10-01 to 2016-12-31 | 7,825,000 | USD | 92 |
| 2016-01-01 to 2016-12-31 | 28,124,000 | USD | 366 |
| 2016-07-01 to 2016-09-30 | 9,427,000 | USD | 92 |
| 2016-04-01 to 2016-06-30 | 6,486,000 | USD | 91 |
| 2016-01-01 to 2016-03-31 | 4,386,000 | USD | 91 |
| 2015-10-01 to 2015-12-31 | 5,146,000 | USD | 92 |
| 2015-01-01 to 2015-12-31 | 10,599,000 | USD | 365 |
| 2015-07-01 to 2015-09-30 | 3,404,000 | USD | 92 |
| 2015-04-01 to 2015-06-30 | 2,571,000 | USD | 91 |
| 2015-01-01 to 2015-03-31 | -522,000 | USD | 90 |
| 2014-01-01 to 2014-12-31 | -4,037,000 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 18,397,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 14,908,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 11,440,000 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-12-31 | 86,589,000 | USD | 366 |
| 2015-01-01 to 2015-12-31 | 45,471,000 | USD | 365 |
| 2014-01-01 to 2014-12-31 | 16,731,000 | USD | 365 |
Inspect the source
- Entity
- PHYSICIANS REALTY TRUST / CIK 0001574540
- Captured
- SEC response SHA-256
88320cb0b703580b6b0d10456cce9b6cf4ae17ff5bb41bcb9d0326e8e3542944
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001574540.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))